Am J Transplant, Volume 21, Suppl 3 Archives - Page 52 of 139 - ATC Abstracts

2021 American Transplant Congress
Improved Patient Survival in DCD Liver Transplantation
O. Bushara¹, J. Alhalel¹, H. Azad¹, T. Cerri², S. Zafer², J. C. Caicedo¹
¹Department of Surgery, Division of Organ Transplantation, Northwestern University Feinberg School of Medicine, Chicago, IL, ²Rosalind Franklin Medical School, Chicago, IL
*Purpose: We aim to investigate longitudinal outcomes in DCD liver transplantation over a 10-year period and elucidate trends in patient survival, biliary complication rates, and…
2021 American Transplant Congress
Temporal Changes in Renal Function Predict Waitlist Death or Deterioration in Pediatric Liver Transplantation
N. Thalji, L. Thalji, S. Ibrahim, T. Diwan, P. Kamath, J. Heimbach
Mayo Clinic Rochester, Minnesota, Rochester, MN
*Purpose: Renal dysfunction at the time of listing predicts inferior waitlist outcomes in pediatric liver transplant candidates, independent of the Pediatric End-Stage Liver Disease (PELD)…
2021 American Transplant Congress
Acute Kidney Injury After Lung Transplantation: Incidence, Risk Factors and Outcomes. Results from a Monocentric Retrospective Cohort Study
M. Gandolfo¹, C. Bellincioni¹, L. Morlacchi², V. Rossetti², F. Blasi², P. Messa¹
¹Nephrology, Ospedale Maggiore Policlinico, Milano, Italy, ²Pneumology, Ospedale Maggiore Policlinico, Milano, Italy
*Purpose: Acute kidney Injury (AKI) occurs in more than 50% of patients after lung transplantation (LTx). Our purpose was to define incidence, risk factors and…
2021 American Transplant Congress
Cancer-Specific Mortality in Solid Organ Transplant Recipients with a Prior Cancer Diagnosis
E. Engels¹, G. Haber¹, A. Hart², C. Lynch³, J. Li⁴, K. Pawlish⁴, B. Qiao⁵, K. Yu¹, R. Pfeiffer¹
¹Natl Cancer Inst, Bethesda, MD, ²Univ of Minnesota, Minneapolis, MN, ³Univ of Iowa, Iowa City, IA, ⁴New Jersey Dept of Health, Trenton, NJ, ⁵New York State Dept of Health, Albany, NY
*Purpose: A history of cancer is increasingly common among solid organ transplant candidates, and transplant-associated immunosuppression may increase recurrence risk. We assessed whether transplantation was…
2021 American Transplant Congress
Are Liver Transplant Center Websites Accessible to All?
C. E. Jacobson¹, R. Olmeda Barrientos², M. A. Anderson³, M. J. Englesbe³, S. A. Waits³, V. S. Valbuena³
¹University of Michigan Medical School, Ann Arbor, MI, ²University Of California – Riverside, School of Medicine, Riverside, CA, ³Department of Surgery, University of Michigan Health System, Ann Arbor, MI
*Purpose: Ensuring equitable access to transplant center information is an important step in combating health disparities in liver transplantation. This study aimed to assess liver…
2021 American Transplant Congress
Seeing is Believing: Efficacy of a Video-based Intervention in Improving Awareness of Skin Cancer Risk for Solid Organ Transplant Recipients
E. Shah¹, S. Michalak¹, R. Haughton¹, B. Fernandez¹, I. Ahronowitz²
¹Keck School of Medicine, Los Angeles, CA, ²Dermatology, Keck School of Medicine, Los Angeles, CA
*Purpose: Our research focuses on the efficacy of using a novel video-based intervention to educate solid organ transplant recipients on their increased risk of skin…
2021 American Transplant Congress
Offer Acceptance Models for Various Endpoints: Initial Response, Final Response, and Conversion from Provisional Yes to Yes
C. Martinez, M. Stuart, A. Placona
United Network for Organ Sharing, Richmond, VA
*Purpose: Offer acceptance models are routinely used for program evaluation and academic research, but the focus tends to be on modelling the final offer response.…
2021 American Transplant Congress
Impact of Insulin Therapy in Pancreas Transplantation Donors on Graft Outcomes: An Analysis of the Optn/unos Database
E. Montagud-Marrahi¹, F. Ausania², Y. Fundora², A. Amor³, E. Esmatjes³, J. Ferrer², I. Revuelta¹, D. Cucchiari¹, J. Rovira⁴, M. Musquera⁵, C. Fondevila², F. Diekmann¹, P. Ventura-Aguiar¹
¹Nephrology and Kidney Transplantation Department, Hospital Clinic de Barcelona, Barcelona, Spain, ²Hepatobiliopancreatic and Liver Transplant Department, Hospital Clinic de Barcelona, Barcelona, Spain, ³Endocrinology Department, Hospital Clinic de Barcelona, Barcelona, Spain, ⁴Laboratori Experimental de Nefrologia I Trasplantament (LENIT), CRB CELLEX, Fundació Clínic, IDIBAPS, Hospital Clinic de Barcelona, Barcelona, Spain, ⁵Urology Department, Hospital Clinic de Barcelona, Barcelona, Spain
*Purpose: Hyperglycemia requiring insulin treatment is frequent in critically ill patients and potential pancreas donors. Information on the impact of donor insulin use on pancreas…
2021 American Transplant Congress
Baseline Levels of Dd-cf Dna After Pancreas Transplantation: Using Dd-cfdna as an Indicator for Pancreas Rejection and Biopsy Avoidance
A. Yoo, I. Qian, A. Riedel, C. Cazac, A. Bartosic, J. S. Bromberg, J. Scalea
Department of Surgery, Division of Transplant, University of Maryland School of Medicine, Baltimore, MD
*Purpose: Donor-derived cell-free DNA (dd-cfDNA) testing, which has been previously validated for monitoring kidney transplant (KTx) rejection, may provide an alternative to pancreas biopsy that…
2021 American Transplant Congress
The Use of Organs from Donors That Do Not Meet Eligibility Criteria in the United States
L. Deroos, M. Lavieri, D. Hutton, W. Marrero, N. Parikh
University of Michigan, Ann Arbor, MI
*Purpose: Increasing the number of organs available for transplantation could reduce waitlist morbidity and mortality for patients with end organ failure. Most transplanted organs come…